- Baird upgraded Cintas Corporation CTAS from Neutral to Outperform. Cintas shares rose 2 percent to $115.25 in pre-market trading.
- Analysts at Morgan Stanley upgraded Valeant Pharmaceuticals Intl Inc VRX from Equal-weight to Overweight. The price target for Valeant has been raised from $33 to $42. Valeant shares gained 9.85 percent to $29.22 in pre-market trading.
- CL King upgraded Patrick Industries, Inc. PATK from Neutral to Buy. Patrick Industries shares gained 5.09 percent to $62.56 in pre-market trading.
- Analysts at Wells Fargo upgraded AveXis Inc AVXS from Market Perform to Outperform. AveXis shares declined 4.38 percent to close at $41.66 on Tuesday.
- PiperJaffray upgraded Markit Ltd INFO from Neutral to Overweight. IHS Markit shares slipped 0.17 percent to close at $35.26 on Tuesday.
- Analysts at Deutsche Bank upgraded Brixmor Property Group Inc BRX from Hold to Buy. Brixmor Property shares declined 0.79 percent to close at $27.55 on Tuesday.
- Analysts at Keefe Bruyette & Woods upgraded IBERIABANK Corp IBKC from Market Perform to Outperform. The price target for IBERIABANK has been raised from $67 to $72. IBERIABANK shares fell 0.05 percent to close at $64.69 on Tuesday.
- Barclays upgraded Cintas Corporation CTAS from Equal-weight to Overweight. The price target for Cintas has been raised from $110 to $130. Cintas shares rose 2 percent to $115.25 in pre-market trading.
- National Bank upgraded Stantec Inc. (USA) STN from Sector Perform to Outperform. Stantec shares rose 0.34 percent to close at $23.42 on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in